PREVAS: prevention of ankylosing spondylitis.
- Conditions
- ankylosing spondylitis, inflammatory back pain, morning stiffness, chronic (low) back pain, arthiritis, buttock pain, dactylitis, enthestitis, psoriasis, non-gonococcal urethritis or cercvicitis
- Registration Number
- NL-OMON29047
- Lead Sponsor
- investigator drive study supported by Wyeth
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Patients to be included must meet the following criteria:
1. Age between 18-45 years, both male and female;
Exclusion Criteria
Specific medical exclusion criteria:
1. Definite AS (modified New York criteria (9));
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammation of the SI- joints on MRI after 16 weeks and after 6 months.
- Secondary Outcome Measures
Name Time Method 1. Disease acitivity after 16 weeks and 6 months (questionnaires, physical examination and labaratory findings);<br /><br>2. Radioactive progression after 3 years;<br /><br>3. Development of A.S.